» Articles » PMID: 22585993

Circumventing Cancer Drug Resistance in the Era of Personalized Medicine

Overview
Journal Cancer Discov
Specialty Oncology
Date 2012 May 16
PMID 22585993
Citations 254
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: All successful cancer therapies are limited by the development of drug resistance. The increase in the understanding of the molecular and biochemical bases of drug efficacy has also facilitated studies elucidating the mechanism(s) of drug resistance. Experimental approaches that can help predict the eventual clinical drug resistance, coupled with the evolution of systematic genomic and proteomic technologies, are rapidly identifying novel resistance mechanisms. In this review, we provide a historical background on drug resistance and a framework for understanding the common ways by which cancers develop resistance to targeted therapies. We further discuss advantages and disadvantages of experimental strategies that can be used to identify drug resistance mechanism(s).

Significance: Increased knowledge of drug resistance mechanisms will aid in the development of effective therapies for patients with cancer. We provide a summary of current knowledge on drug resistance mechanisms and experimental strategies to identify and study additional drug resistance pathways.

Citing Articles

Therapeutic Potential of Cinnamon Oil: Chemical Composition, Pharmacological Actions, and Applications.

Guo J, Jiang X, Tian Y, Yan S, Liu J, Xie J Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770541 PMC: 11677886. DOI: 10.3390/ph17121700.


Investigating the role of HSP90 in cancer cell phenotypic plasticity.

Sollars V, Chapman A, Liang N, Myers S J Breast Cancer Res. 2024; 4(1):5-10.

PMID: 39363892 PMC: 11448696. DOI: 10.46439/breastcancer.4.021.


Slowing Down the "Magic Bullet": Encapsulation of Imatinib in Fe-MOF for Cardiotoxicity Reduction and Improvement in Anticancer Activity.

Strzempek W, Menaszek E, Papiez M, Gil B Molecules. 2024; 29(16).

PMID: 39202897 PMC: 11357391. DOI: 10.3390/molecules29163818.


Identification of resistance mechanisms to small-molecule inhibition of TEAD-regulated transcription.

Kulkarni A, Mohan V, Tang T, Post L, Chan Y, Manning M EMBO Rep. 2024; 25(9):3944-3969.

PMID: 39103676 PMC: 11387499. DOI: 10.1038/s44319-024-00217-3.


Discovery of Potent Isoquinolinequinone -Oxides to Overcome Cancer Multidrug Resistance.

Kruschel R, Barbosa M, Almeida M, Xavier C, Vasconcelos M, McCarthy F J Med Chem. 2024; 67(16):13909-13924.

PMID: 39093920 PMC: 11345829. DOI: 10.1021/acs.jmedchem.4c00705.